IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v417y2002i6884d10.1038_417095a.html
   My bibliography  Save this article

HIV preferentially infects HIV-specific CD4+ T cells

Author

Listed:
  • Daniel C. Douek

    (Vaccine Research Center, NIAID, NIH
    Medicine Branch, NCI, NIH)

  • Jason M. Brenchley

    (Vaccine Research Center, NIAID, NIH)

  • Michael R. Betts

    (Vaccine Research Center, NIAID, NIH)

  • David R. Ambrozak

    (Vaccine Research Center, NIAID, NIH)

  • Brenna J. Hill

    (Vaccine Research Center, NIAID, NIH)

  • Yukari Okamoto

    (Vaccine Research Center, NIAID, NIH)

  • Joseph P. Casazza

    (University of Texas Southwestern Medical Center)

  • Janaki Kuruppu

    (Vaccine Research Center, NIAID, NIH)

  • Kevin Kunstman

    (Northwestern University Medical School)

  • Steven Wolinsky

    (Northwestern University Medical School)

  • Zvi Grossman

    (NIAID, NIH
    Tel Aviv University)

  • Mark Dybul

    (NIAID, NIH)

  • Annette Oxenius

    (John Radcliffe Hospital)

  • David A. Price

    (John Radcliffe Hospital)

  • Mark Connors

    (NIAID, NIH)

  • Richard A. Koup

    (Vaccine Research Center, NIAID, NIH)

Abstract

HIV infection is associated with the progressive loss of CD4+ T cells through their destruction or decreased production1,2. A central, yet unresolved issue of HIV disease is the mechanism for this loss, and in particular whether HIV-specific CD4+ T cells are preferentially affected3,4,5. Here we show that HIV-specific memory CD4+ T cells in infected individuals contain more HIV viral DNA than other memory CD4+ T cells, at all stages of HIV disease. Additionally, following viral rebound during interruption of antiretroviral therapy, the frequency of HIV viral DNA in the HIV-specific pool of memory CD4+ T cells increases to a greater extent than in memory CD4+ T cells of other specificities. These findings show that HIV-specific CD4+ T cells are preferentially infected by HIV in vivo. This provides a potential mechanism to explain the loss of HIV-specific CD4+ T-cell responses, and consequently the loss of immunological control of HIV replication6. Furthermore, the phenomenon of HIV specifically infecting the very cells that respond to it adds a cautionary note to the practice of structured therapy interruption.

Suggested Citation

  • Daniel C. Douek & Jason M. Brenchley & Michael R. Betts & David R. Ambrozak & Brenna J. Hill & Yukari Okamoto & Joseph P. Casazza & Janaki Kuruppu & Kevin Kunstman & Steven Wolinsky & Zvi Grossman & M, 2002. "HIV preferentially infects HIV-specific CD4+ T cells," Nature, Nature, vol. 417(6884), pages 95-98, May.
  • Handle: RePEc:nat:nature:v:417:y:2002:i:6884:d:10.1038_417095a
    DOI: 10.1038/417095a
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/417095a
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/417095a?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Becca Asquith, 2008. "The Evolutionary Selective Advantage of HIV-1 Escape Variants and the Contribution of Escape to the HLA-Associated Risk of AIDS Progression," PLOS ONE, Public Library of Science, vol. 3(10), pages 1-10, October.
    2. Haibin Wang & Rui Xu, 2013. "Stability and Hopf Bifurcation in an HIV-1 Infection Model with Latently Infected Cells and Delayed Immune Response," Discrete Dynamics in Nature and Society, Hindawi, vol. 2013, pages 1-12, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:417:y:2002:i:6884:d:10.1038_417095a. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.